Rethinking coronary artery disease: from ischaemia to atheroma - Implications of the Lancet Commission for Interventional Cardiology

With the collaboration of EuroIntervention and the Lancet

Anchorperson: D. Capodanno

Spokesperson: F. Geraldes

Summary

This session invites a re-evaluation of coronary artery disease by shifting focus from ischemia to atheroma, integrating insights from the Lancet Commission for Interventional Cardiology. It explores the significance of plaque burden, biology, and inflammation in guiding PCI decisions and outlines the future role of PCI within a comprehensive systemic model of atherosclerotic vascular disease management.

Learning Objectives

To reframe our concept of coronary artery disease and understand the implications for PCI
To integrate plaque burden, plaque biology and inflammation into interventional decision-making
To define the future role of PCI within a lifelong systemic model of atherosclerotic vascular disease

Presentations available when logged in:

Welcome and session objectives
From "obstructive" to "atherosclerotic" coronary artery disease: what exactly are we treating?
Case-based discussion 1: angiography, physiology, intra-coronary imaging and inflammation: what should drive decision-making at the time of PCI?
Case-based discussion 2: do we treat the culprit lesion or the disease?
Session evaluation and key learnings

Your free My PCR account will enable you to:

Become a PCR Companion
Access slide presentations from PCR Courses
Watch session videos and LIVE cases
Discuss cases with your peers
Submit and register for PCR Courses
Register for and view PCR Webinars
Read a selection of articles in EuroIntervention
And more…

Rethinking coronary artery disease: from ischaemia to atheroma - Implications of the Lancet Commission for Interventional Cardiology

With the collaboration of EuroIntervention and the Lancet

Learning Objectives

Log in or create account for free